Developer docs
API playgroundTry for free, no card

Search company profiles

AmphiStar

Full company profile

uuid0000hm8

Namestring
AmphiStar
Legal namestring
AmphiStar BV
Websiteurl
amphistar.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

AmphiStar BV is a Belgian biotechnology company founded in 2021 as a spin-off from Ghent University's InBio research group and the Bio Base Europe Pilot Plant. It develops, scales up, produces, and sells sophorolipid biosurfactants manufactured entirely from bio-based waste and side streams (such as food waste, crude glycerine, and agricultural by-products) using proprietary microbial fermentation with the yeast Starmerella bombicola. The company's core technology combines synthetic biology, patented continuous fermentation processes (validated for 75 days using only waste feedstocks), and bioprocess scale-up demonstrated at 15 m³, and is encapsulated in its AmphiNova® platform of more than 80 designer biosurfactant molecules. Its commercial product portfolio comprises AmphiCare® for personal care (shampoos, facial cleansers, makeup removers, skincare) and AmphiClean® for home care (dishwashing, laundry, multi-surface cleaners), with sophorolipid variants available in standard and ultra-purity grades.

AmphiStar operates a B2B ingredient-supply business model selling to consumer-product manufacturers in Personal Care, Home Care, and Industrial & Institutional cleaning. Pricing is quote-based and not publicly disclosed; revenue is generated through both direct product sales and Joint Development Agreements (technology licensing and co-development) for specific AmphiNova® molecules. The company reaches global markets exclusively through regional distribution partnerships: Stepan Company (EMEA Home Care and I&I, branded NOVATENSIA™ SL), Kensing LLC (North America Personal Care and Home Care, branded Regenyl™ and Revolis™), and Caldic (European Personal Care). Named end-customers are limited but include Ecover, which launched the first waste-based sophorolipid consumer product through the EU-funded WASTE2FUNC Project. Pricing is positioned as a premium sustainable alternative, supported by third-party-verified Life Cycle Assessment data showing 4× lower CO2, 18× lower water use, and 15× lower biodiversity impact versus conventional surfactant benchmarks.

AmphiStar has raised more than €21M cumulatively across pre-Series A equity (€6M led by ECBF in April 2024), non-dilutive SPRIND grants (€6M across 2023–2025), and a €12.5M EIC blended-funding award in July 2025. The team is led by CEO Pierre-Franck Valentin (former surfactants industry executive, appointed April 2024) alongside the four scientific co-founders and CFO Wim Allegaert (joined June 2025). The company currently employs 11–50 people at its Ghent headquarters and is engineering a 1,000-tonnes-per-annum production facility while expanding into new geographies and verticals.

Short descriptiontext

AmphiStar BV is a Belgian biotech company founded in 2021 that develops, scales, and sells sophorolipid biosurfactants made entirely from bio-based waste and side streams, serving consumer-product manufacturers in Personal Care, Home Care, and Industrial & Institutional cleaning via its AmphiCare®, AmphiClean®, and AmphiNova® platforms and regional distribution partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGent, Belgium
HQ citystring
Gent
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbial biosurfactant production, sophorolipid manufacturing, sustainable surfactant ingredients, biobased waste upcycling, personal care surfactants
Industry3 codes
PRIMARYEUAAAIAE
Bio-based Surfactants, Detergent Ingredients & Oleochemicals
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAB
Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code2 codes
  • Surface Active Agent Manufacturing325613
  • Soap and Cleaning Compound Manufacturing32561
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Biosurfactants
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Biosurfactant Product Sales
TypeOne Time License
Description

AmphiStar generates revenue through the sale of microbial biosurfactant products (AmphiCare® for personal care, AmphiClean® for home care) to consumer product manufacturers. Products are sold in various purity levels and formulations as drop-in replacements for conventional surfactants.

amphistar.com
2Technology Licensing and Co-development
TypeLicensing Royalties
Description

Joint Development Agreements (JDAs) with partners for specific AmphiNova molecules, enabling targeted strategic co-development. Partnerships include technology transfer for localized production in different regions.

amphistar.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Custom quote-based pricing for B2B customers
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Direct inquiry required for quotes. Products offered as standard purity or ultra purity grades with customization options.

amphistar.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AmphiNova®
Description

Proprietary platform of over 80 biosurfactant molecules developed through synthetic biology and bioprocessing for next-generation sustainable surfactants

amphistar.com
+2 more records
Core offering1 text field

AmphiStar develops, scales up, produces, and sells microbial sophorolipid biosurfactants manufactured entirely from biobased waste and side streams using proprietary continuous fermentation technology. The company supplies these high-performance, sustainable biosurfactant ingredients as drop-in replacements for conventional surfactants to consumer product manufacturers serving personal care, home care, and industrial & institutional (I&I) cleaning markets. Revenue is generated through direct product sales (AmphiCare®, AmphiClean®, sophorolipid portfolio), Joint Development Agreements, and technology licensing via regional distribution partners including Stepan, Kensing, and Caldic.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4× reduction in CO₂ emissions compared to non-upcycled sophorolipids, 6× vs synthetic SLES, 9.5× vs Amine Oxides
+4 more records
Product overview1 text field

AmphiStar offers a portfolio of microbial biosurfactants produced entirely from bio-based waste and side streams. The core product line consists of AmphiCare® (personal care) and AmphiClean® (home care), which were the first commercially available fully upcycled biosurfactants launched in October 2024. The AmphiNova® platform extends the portfolio with 80+ designer biosurfactant molecules for specialized applications. The sophorolipid portfolio includes high lactonic, high acidic, and customized mixture formulations available in standard and ultra purity levels, serving diverse markets from cosmetics to industrial cleaning.

Product and service4 records
1AmphiCare®
CategoryBiosurfactants
Description

AmphiCare® is AmphiStar's first fully upcycled sophorolipid biosurfactant designed for personal care applications including hand soaps, shampoos, facial cleansers, makeup removers, moisturizers, body lotions, and wet wipes. It functions as emulsifier and co-surfactant in both rinse-off and leave-on formulations, is certified non-irritant to eyes (OECD 492B compliant), mild on skin, and free from sulfates, palm oil, fossil-based ingredients, and 1,4-dioxane. Targeted at personal care and cosmetics brand owners seeking sustainable, mild, high-performance surfactant ingredients.

2AmphiClean®
CategoryBiosurfactants
Description

AmphiClean® is AmphiStar's fully upcycled sophorolipid biosurfactant formulated for home care applications including dishwashing liquids, laundry detergents, multi-surface cleaners, degreasers, and hard surface cleaners. It delivers high-performance cleaning with 50-70% lower CO₂ emissions compared to fossil- and palm-based surfactants. Targeted at home care and cleaning product manufacturers seeking high-performance, biodegradable cleaning ingredients with superior sustainability profiles.

3AmphiNova® Biosurfactant Platform
CategoryBiosurfactant platform
Description

AmphiNova® is AmphiStar's proprietary platform comprising more than 80 distinct biosurfactant molecules developed through 15+ years of synthetic biology and bioprocessing research. It enables design and delivery of designer sophorolipid surfactants with tailored functional properties for specific application requirements across personal care, home care, and industrial markets. Accessed by customers through Joint Development Agreements (JDAs) and direct market launches of selected molecules, AmphiNova® extends the portfolio beyond the initial AmphiCare® and AmphiClean® offerings.

4Sophorolipid Product Portfolio
CategoryBiosurfactants
Description

The Sophorolipid Product Portfolio is AmphiStar's diverse range of second-generation (2G) sophorolipids including high lactonic, high acidic, and customized lactonic/acidic mixtures available in standard and ultra purity levels. Includes variants such as acetylated lactonic sophorolipid C18:1, non-acetylated acidic sophorolipid C18:1, bola sophorolipids, and alkyl sophorosides with varying HLB values for different applications. Targeted at formulators and product developers in cosmetics, home care, and industrial cleaning who require specific functional properties and purity grades.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-29
Description

Strategic partnership to bring AmphiStar's upcycled biosurfactants to North American personal care and home care markets. Kensing distributes Regenyl™ (Personal Care) and Revolis™ (Home Care) products and will develop regionally sourced circular feedstocks with near-term plans to fully onshore production in the US.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-25
Description

Exclusive distribution partnership for AmphiStar's bio-based surfactants across Europe, Middle East and Africa (EMEA) targeting Home Care and Industrial & Institutional cleaning markets. Stepan provides formulation expertise and established commercial channels. Products sold under NOVATENSIA™ SL brand.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-01
Description

Exclusive partnership to distribute and promote AmphiStar's 100% upcycled biosurfactants for personal care applications across Europe. Caldic leverages its extensive European customer base and application labs to accelerate biosurfactant adoption.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-05-16
Description

First market introduction partner for waste-based sophorolipids through WASTE2FUNC Project. Ecover launched consumer product featuring AmphiStar's biosurfactants.

5Bio Base Europe Pilot Plant (BBEPP)
Strategic tierCoreTypeOthersAnnounced on2021-01-01
Description

Co-founder organization and current shareholder. Independent pilot facility for process development, scale-up and custom manufacturing of innovative biobased products. AmphiStar originated from collaboration between Ghent University and BBEPP.

amphistar.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based biosurfactant startup producing sophorolipids and glycolipids via fermentation. Closest direct competitor to AmphiStar in the yeast-derived biosurfactant space, also targeting personal care and home care applications.

TypeBroad incumbent
Description

Major global surfactant manufacturer and AmphiStar's EMEA distribution partner. Operates in the same end markets (personal care, home care, I&I) with petrochemical-derived surfactants, representing both a partner and competitive threat.

TypeRegional player
Description

North American specialty ingredients manufacturer and AmphiStar's NA distribution partner producing Regenyl™ and Revolis™ brands. Operates in same surfactant value chain but as a regional downstream partner/competitor.

4TeeGene Biotech
TypeEmerging player
Description

UK-based biosurfactant startup developing microbial sophorolipids and rhamnolipids for cosmetics and cleaning. Direct technology overlap with AmphiStar at earlier stage.

TypeDirect peer
Description

US-based biosurfactant producer (rhamnolipids and sophorolipids) serving oil & gas, agriculture, and personal care. Directly comparable technology platform and go-to-market motion via B2B ingredient sales.

TypeBroad incumbent
Description

Global specialty chemicals incumbent with biosurfactant (REWOFERM rhamnolipid) line, broad surfactant portfolio, and deep CPG customer relationships. Represents the scaled incumbent AmphiStar ultimately competes with for biobased share.

TypeEmerging player
Description

US-based startup developing sugar-based and glycolipid biosurfactants via enzymatic and chemo-enzymatic processes. Comparable early-stage biosurfactant innovator with overlap in personal care applications.

TypeBroad incumbent
Description

UK-listed specialty chemicals leader serving personal care, home care, and I&I with biobased and conventional surfactants. Comparable customer base and sustainability positioning in the CPG ingredient market.

TypeBroad incumbent
Description

Specialty chemicals and bioproducts company (including AGAIA Technologies biosurfactants) supplying life sciences and industrial customers. Comparable fermentation-based specialty ingredients business.

TypeBroad incumbent
Description

World's largest chemical company with extensive surfactant portfolio (Plantapon, Texapon, Dehyton brands) serving the same personal care and home care customers AmphiStar targets. Sets the benchmark on price-performance that biosurfactants must match.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AmphiStar

Biosurfactantsamphistar.com

AmphiStar BV is a Belgian biotech company founded in 2021 that develops, scales, and sells sophorolipid biosurfactants made entirely from bio-based waste and side streams, serving consumer-product manufacturers in Personal Care, Home Care, and Industrial & Institutional cleaning via its AmphiCare®, AmphiClean®, and AmphiNova® platforms and regional distribution partnerships.

What AmphiStar does

AmphiStar BV is a Belgian biotechnology company founded in 2021 as a spin-off from Ghent University's InBio research group and the Bio Base Europe Pilot Plant. It develops, scales up, produces, and sells sophorolipid biosurfactants manufactured entirely from bio-based waste and side streams (such as food waste, crude glycerine, and agricultural by-products) using proprietary microbial fermentation with the yeast Starmerella bombicola. The company's core technology combines synthetic biology, patented continuous fermentation processes (validated for 75 days using only waste feedstocks), and bioprocess scale-up demonstrated at 15 m³, and is encapsulated in its AmphiNova® platform of more than 80 designer biosurfactant molecules. Its commercial product portfolio comprises AmphiCare® for personal care (shampoos, facial cleansers, makeup removers, skincare) and AmphiClean® for home care (dishwashing, laundry, multi-surface cleaners), with sophorolipid variants available in standard and ultra-purity grades.

AmphiStar operates a B2B ingredient-supply business model selling to consumer-product manufacturers in Personal Care, Home Care, and Industrial & Institutional cleaning. Pricing is quote-based and not publicly disclosed; revenue is generated through both direct product sales and Joint Development Agreements (technology licensing and co-development) for specific AmphiNova® molecules. The company reaches global markets exclusively through regional distribution partnerships: Stepan Company (EMEA Home Care and I&I, branded NOVATENSIA™ SL), Kensing LLC (North America Personal Care and Home Care, branded Regenyl™ and Revolis™), and Caldic (European Personal Care). Named end-customers are limited but include Ecover, which launched the first waste-based sophorolipid consumer product through the EU-funded WASTE2FUNC Project. Pricing is positioned as a premium sustainable alternative, supported by third-party-verified Life Cycle Assessment data showing 4× lower CO2, 18× lower water use, and 15× lower biodiversity impact versus conventional surfactant benchmarks.

AmphiStar has raised more than €21M cumulatively across pre-Series A equity (€6M led by ECBF in April 2024), non-dilutive SPRIND grants (€6M across 2023–2025), and a €12.5M EIC blended-funding award in July 2025. The team is led by CEO Pierre-Franck Valentin (former surfactants industry executive, appointed April 2024) alongside the four scientific co-founders and CFO Wim Allegaert (joined June 2025). The company currently employs 11–50 people at its Ghent headquarters and is engineering a 1,000-tonnes-per-annum production facility while expanding into new geographies and verticals.

AmphiStar firmographics

Firmographics
Name
AmphiStar
Legal name
AmphiStar BV
Website
https://amphistar.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
AmphiStar BV is a Belgian biotech company founded in 2021 that develops, scales, and sells sophorolipid biosurfactants made entirely from bio-based waste and side streams, serving consumer-product manufacturers in Personal Care, Home Care, and Industrial & Institutional cleaning via its AmphiCare®, AmphiClean®, and AmphiNova® platforms and regional distribution partnerships.
Ownership category
akta.pro rank

AmphiStar industry classification

Industry
Product category
Biosurfactants
NAICS
Surface Active Agent Manufacturing (325613), Soap and Cleaning Compound Manufacturing (32561)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYEUAAAIAE
Bio-based Surfactants, Detergent Ingredients & Oleochemicals
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAB
Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Microbial biosurfactant production
  • Sophorolipid manufacturing
  • Sustainable surfactant ingredients
  • Biobased waste upcycling
  • Personal care surfactants

Where AmphiStar is headquartered

Location

Headquarters

HQ city
Gent
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

AmphiStar business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Biosurfactant Product Sales: AmphiStar generates revenue through the sale of microbial biosurfactant products (AmphiCare® for personal care, AmphiClean® for home care) to consumer product manufacturers. Products are sold in various purity levels and formulations as drop-in replacements for conventional surfactants.
  2. Technology Licensing and Co-development: Joint Development Agreements (JDAs) with partners for specific AmphiNova molecules, enabling targeted strategic co-development. Partnerships include technology transfer for localized production in different regions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quote-based pricing for B2B customers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

AmphiStar product offering

Product offering

Core offering

AmphiStar develops, scales up, produces, and sells microbial sophorolipid biosurfactants manufactured entirely from biobased waste and side streams using proprietary continuous fermentation technology. The company supplies these high-performance, sustainable biosurfactant ingredients as drop-in replacements for conventional surfactants to consumer product manufacturers serving personal care, home care, and industrial & institutional (I&I) cleaning markets. Revenue is generated through direct product sales (AmphiCare®, AmphiClean®, sophorolipid portfolio), Joint Development Agreements, and technology licensing via regional distribution partners including Stepan, Kensing, and Caldic.

Product overview

AmphiStar offers a portfolio of microbial biosurfactants produced entirely from bio-based waste and side streams. The core product line consists of AmphiCare® (personal care) and AmphiClean® (home care), which were the first commercially available fully upcycled biosurfactants launched in October 2024. The AmphiNova® platform extends the portfolio with 80+ designer biosurfactant molecules for specialized applications. The sophorolipid portfolio includes high lactonic, high acidic, and customized mixture formulations available in standard and ultra purity levels, serving diverse markets from cosmetics to industrial cleaning.

Differentiator

Problem solved

Functional benefit

Brands

  • AmphiNova®: Proprietary platform of over 80 biosurfactant molecules developed through synthetic biology and bioprocessing for next-generation sustainable surfactants
  • AmphiCare®
  • AmphiClean®

Products and services

  • AmphiCare® AmphiCare® is AmphiStar's first fully upcycled sophorolipid biosurfactant designed for personal care applications including hand soaps, shampoos, facial cleansers, makeup removers, moisturizers, body lotions, and wet wipes. It functions as emulsifier and co-surfactant in both rinse-off and leave-on formulations, is certified non-irritant to eyes (OECD 492B compliant), mild on skin, and free from sulfates, palm oil, fossil-based ingredients, and 1,4-dioxane. Targeted at personal care and cosmetics brand owners seeking sustainable, mild, high-performance surfactant ingredients.
  • AmphiClean® AmphiClean® is AmphiStar's fully upcycled sophorolipid biosurfactant formulated for home care applications including dishwashing liquids, laundry detergents, multi-surface cleaners, degreasers, and hard surface cleaners. It delivers high-performance cleaning with 50-70% lower CO₂ emissions compared to fossil- and palm-based surfactants. Targeted at home care and cleaning product manufacturers seeking high-performance, biodegradable cleaning ingredients with superior sustainability profiles.
  • AmphiNova® Biosurfactant Platform AmphiNova® is AmphiStar's proprietary platform comprising more than 80 distinct biosurfactant molecules developed through 15+ years of synthetic biology and bioprocessing research. It enables design and delivery of designer sophorolipid surfactants with tailored functional properties for specific application requirements across personal care, home care, and industrial markets. Accessed by customers through Joint Development Agreements (JDAs) and direct market launches of selected molecules, AmphiNova® extends the portfolio beyond the initial AmphiCare® and AmphiClean® offerings.
  • Sophorolipid Product Portfolio The Sophorolipid Product Portfolio is AmphiStar's diverse range of second-generation (2G) sophorolipids including high lactonic, high acidic, and customized lactonic/acidic mixtures available in standard and ultra purity levels. Includes variants such as acetylated lactonic sophorolipid C18:1, non-acetylated acidic sophorolipid C18:1, bola sophorolipids, and alkyl sophorosides with varying HLB values for different applications. Targeted at formulators and product developers in cosmetics, home care, and industrial cleaning who require specific functional properties and purity grades.

Quantifiable outcome

  • 4× reduction in CO₂ emissions compared to non-upcycled sophorolipids, 6× vs synthetic SLES, 9.5× vs Amine Oxides
  • +4 more outcomes

Companies that use AmphiStar

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

AmphiStar technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AmphiStar partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Kensing LLCcoreChannel Partner/ Reseller/ Distributor · 29 April 2026Strategic partnership to bring AmphiStar's upcycled biosurfactants to North American personal care and home care markets. Kensing distributes Regenyl™ (Personal Care) and Revolis™ (Home Care) products and will develop regionally sourced circular feedstocks with near-term plans to fully onshore production in the US.
  • Stepan CompanycoreChannel Partner/ Reseller/ Distributor · 25 November 2025Exclusive distribution partnership for AmphiStar's bio-based surfactants across Europe, Middle East and Africa (EMEA) targeting Home Care and Industrial & Institutional cleaning markets. Stepan provides formulation expertise and established commercial channels. Products sold under NOVATENSIA™ SL brand.
  • CaldiccoreChannel Partner/ Reseller/ Distributor · 1 October 2025Exclusive partnership to distribute and promote AmphiStar's 100% upcycled biosurfactants for personal care applications across Europe. Caldic leverages its extensive European customer base and application labs to accelerate biosurfactant adoption.
  • EcoverminorStrategic or Co-development Partner · 16 May 2023First market introduction partner for waste-based sophorolipids through WASTE2FUNC Project. Ecover launched consumer product featuring AmphiStar's biosurfactants.
  • Bio Base Europe Pilot Plant (BBEPP)coreOthers · 1 January 2021Co-founder organization and current shareholder. Independent pilot facility for process development, scale-up and custom manufacturing of innovative biobased products. AmphiStar originated from collaboration between Ghent University and BBEPP.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

AmphiStar competitors and assessment

Company assessment

Direct peers

  • Holiferm: UK-based biosurfactant startup producing sophorolipids and glycolipids via fermentation. Closest direct competitor to AmphiStar in the yeast-derived biosurfactant space, also targeting personal care and home care applications.
  • Locus Fermentation Solutions: US-based biosurfactant producer (rhamnolipids and sophorolipids) serving oil & gas, agriculture, and personal care. Directly comparable technology platform and go-to-market motion via B2B ingredient sales.

Broad incumbents

  • Stepan Company: Major global surfactant manufacturer and AmphiStar's EMEA distribution partner. Operates in the same end markets (personal care, home care, I&I) with petrochemical-derived surfactants, representing both a partner and competitive threat.
  • Evonik Industries: Global specialty chemicals incumbent with biosurfactant (REWOFERM rhamnolipid) line, broad surfactant portfolio, and deep CPG customer relationships. Represents the scaled incumbent AmphiStar ultimately competes with for biobased share.
  • Croda International: UK-listed specialty chemicals leader serving personal care, home care, and I&I with biobased and conventional surfactants. Comparable customer base and sustainability positioning in the CPG ingredient market.
  • BioSynth Group: Specialty chemicals and bioproducts company (including AGAIA Technologies biosurfactants) supplying life sciences and industrial customers. Comparable fermentation-based specialty ingredients business.
  • BASF Care Chemicals: World's largest chemical company with extensive surfactant portfolio (Plantapon, Texapon, Dehyton brands) serving the same personal care and home care customers AmphiStar targets. Sets the benchmark on price-performance that biosurfactants must match.

Regional players

  • Kensing LLC: North American specialty ingredients manufacturer and AmphiStar's NA distribution partner producing Regenyl™ and Revolis™ brands. Operates in same surfactant value chain but as a regional downstream partner/competitor.

Emerging players

  • TeeGene Biotech: UK-based biosurfactant startup developing microbial sophorolipids and rhamnolipids for cosmetics and cleaning. Direct technology overlap with AmphiStar at earlier stage.
  • GlycoSurf: US-based startup developing sugar-based and glycolipid biosurfactants via enzymatic and chemo-enzymatic processes. Comparable early-stage biosurfactant innovator with overlap in personal care applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AmphiStar social profiles

Digital presence

AmphiStar compliance and trust

Trust signal

Compliance1 record

AmphiStar financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AmphiStar leadership team

Management profile

Number of profiles

Profiles8 records

AmphiStar funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AmphiStar M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AmphiStar

What does AmphiStar do?

AmphiStar develops, scales up, produces, and sells microbial sophorolipid biosurfactants manufactured entirely from biobased waste and side streams using proprietary continuous fermentation technology. The company supplies these high-performance, sustainable biosurfactant ingredients as drop-in replacements for conventional surfactants to consumer product manufacturers serving personal care, home care, and industrial & institutional (I&I) cleaning markets. Revenue is generated through direct product sales (AmphiCare®, AmphiClean®, sophorolipid portfolio), Joint Development Agreements, and technology licensing via regional distribution partners including Stepan, Kensing, and Caldic.

Is AmphiStar a public or private company?

AmphiStar is a private company. It is classified as venture growth investor backed and is currently operating.

When was AmphiStar founded?

AmphiStar was founded in 2021. It employs 11 to 50 people.

Where is AmphiStar based?

AmphiStar is headquartered in Gent, Belgium, in the Europe region.

How does AmphiStar make money?

Two revenue lines are on record. Biosurfactant Product Sales are the primary driver. The others are technology Licensing and Co-development.

Who are AmphiStar's main competitors?

Direct peers on record are Holiferm and Locus Fermentation Solutions. Broad incumbents are Stepan Company, Evonik Industries, Croda International, BioSynth Group and BASF Care Chemicals. Kensing LLC is listed as a regional player. Emerging players are TeeGene Biotech and GlycoSurf.

Does AmphiStar have an API?

No public API is recorded for AmphiStar.

What industry is AmphiStar in?

AmphiStar's product category is Biosurfactants. Its primary akta.pro industry code is EUAAAIAE, Bio-based Surfactants, Detergent Ingredients & Oleochemicals, with a secondary code of EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its NAICS code is 325613 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cosmetics BusinessAmphiStar and Kensing announce strategic partnership to bring upcycled biosurfactants to the North American personal care marketAmphiStar and Kensing announced a strategic partnership to bring upcycled biosurfactants to the North American personal care market. Kensing will launch AmphiStar's biosurfactants, developed from agri-food side streams, with plans to fully onshore US production. The partnership also includes co-developing AmphiStar's 80+ biosurfactant platform for future commercialization.openPR.comAn Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Microbial Bio-Surfactants MarketThe Business Research Company released a market overview reporting that the global microbial bio-surfactants market is projected to reach $1.71 billion by 2030, growing at a compound annual growth rate of 14.6%. In a notable 2025 development, Belgium-based AmphiStar NV partnered with US-based Kensing LLC to introduce upcycled biosurfactants to the North American personal care market, combining AmphiStar's fermentation and upcycling technologies with Kensing's formulation expertise and distribution channels. The report identifies key market drivers including heightened demand for sustainable chemical solutions, increased investments in industrial biotechnology, and growing applications across personal care, food processing, agriculture, and industrial sectors.Cosmetics & ToiletriesCaldic x AmphiStar Partner to Promote Upcycled, Footprint Friendly Biosurfactants Across EuropeCaldic, a global ingredient distributor, announced an exclusive partnership with Belgian biotech innovator AmphiStar to distribute and promote AmphiStar's 100% upcycled biosurfactants across Europe for personal care applications. A recent Life Cycle Analysis demonstrated that these biosurfactants achieve a fourfold reduction in CO₂ equivalent emissions and a 50% overall reduction in environmental impact compared to non-upcycled alternatives, while being fully compliant with EU Green Deal and Biotech Act requirements. The partnership aims to accelerate mainstream adoption of sustainable biosurfactants, building on AmphiStar's existing North American distribution collaboration with US chemicals company Kensing.Environment+Energy LeaderStepan, AmphiStar Partner on EMEA BiosurfactantsStepan Company and Belgium-based AmphiStar have formed an exclusive distribution partnership covering AmphiStar's portfolio of upcycled microbial biosurfactants across Europe, the Middle East, and Africa, targeting Home Care and Industrial & Institutional cleaning sectors. AmphiStar manufactures biosurfactants entirely from waste and side streams, avoiding fossil and palm feedstocks, while Stepan will provide technical guidance to help customers incorporate these materials into liquid and powder formulations at scale. The collaboration responds to EU regulatory pressures around sustainability and companies' Scope 3 reduction targets, with both companies positioned to benefit from rising demand for low-carbon ingredients.StepanStepan and AmphiStar announce exclusive EMEA distribution partnership in Home Care and I&IStepan Company and AmphiStar have announced an exclusive distribution partnership for AmphiStar's bio-based surfactants across Europe, the Middle East, and Africa (EMEA), focusing on Home Care and Industrial & Institutional cleaning markets. This partnership aims to drive the adoption of sustainable cleaning solutions, leveraging AmphiStar's biosurfactants which offer a significantly lower carbon footprint compared to conventional alternatives. Stepan's expertise in formulation and established networks is expected to enhance the market reach of these sustainable products.TrendHunter.comUpcycled Biosurfactants PartnershipsCaldic partnered with AmphiStar to exclusively distribute and promote AmphiStar's 100% upcycled biosurfactants for personal care applications in Europe. The biosurfactants are derived from upcycled bio-based waste and side streams, aligning with the EU's Green Deal and Biotech Act. The partnership aims to accelerate adoption of these sustainable ingredients in the personal care sector.Tech.euAmphiStar secures €2.5M SPRIND funding to speed circular biosurfactantsAmphiStar received €2.5M from SPRIND to accelerate continuous manufacturing of its microbial biosurfactants. This is its third consecutive award, bringing total support to €6M. The funding will advance continuous fermentation and commercialization of new biosurfactant molecules.AmphistarAmphiStar Secures €12.5m EIC FundingAmphiStar has received €2.5 million in funding from Germany's SPRIND agency to develop its microbial biosurfactants using sustainable waste feedstocks. The funding supports the company's advancement in continuous fermentation technology and promotes market-ready, environmentally friendly ingredients.StartbaseAmphiStar receives 2.5 million euros in SPRIND fundingBelgian start-up AmphiStar, which specializes in microbial biosurfactants produced through microbial fermentation, has received 2.5 million euros in funding from SPRIND, the German agency for breakthrough innovations. The funding will be used to optimize the company's continuous fermentation technology and accelerate commercialization of biosurfactant molecules produced from upcycled bio-based waste streams. This represents the third round of SPRIND funding for AmphiStar, following €1.5 million in 2023 and €2 million in 2024.